Since the majority of IL-33 staining was detected outside the tumor core, we performed immunolabeling for IL-33 in U3013 and U3024 cells cultured in vitro to evaluate inherent IL-33 levels in the grafted GBM cells. This evidence concerns the gene IL33 and glioblastoma.